Screener
Sabra Healthcare SBRA Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Stock-based compensation expense | 3,098 | 2,711 |
| Recovery of loan losses | (213) | (173) |
| Impairment of real estate | 440 | — |
| Income from unconsolidated joint ventures | (1,912) | (218) |
| Distributions of earnings from unconsolidated joint ventures | 1,657 | 2,368 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, prepaid expenses and other assets, net | (1,534) | (2,822) |
| Accounts payable and accrued liabilities | 2,113 | (4,706) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's net gains (losses) on investments?
- Sabra Healthcare (SBRA) reported net gains (losses) on investments of $1.91M in Q1 2026.
- How has Sabra Healthcare's net gains (losses) on investments changed year-over-year?
- Sabra Healthcare's net gains (losses) on investments increased by 777.1% year-over-year, from $218K to $1.91M.
- What is the long-term trend for Sabra Healthcare's net gains (losses) on investments?
- Over 3 years (2021 to 2025), Sabra Healthcare's net gains (losses) on investments has grown at a -48.0% compound annual growth rate (CAGR), from -$27.96M to $3.93M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about Sabra Healthcare's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude